Detection of PD-L1 Expression in Temozolomide-Resistant Glioblastoma by Using PD-L1 Antibodies Conjugated with Lipid‑Coated Superparamagnetic Iron Oxide
Gilbert Aaron Lee,1,2 Wan-Li Lin,1 Duen-Pang Kuo,3 Yi-Tien Li,4,5 Yu-Wei Chang,1 Yung-Chieh Chen,4,6 Shiu-Wen Huang,1,7,8 Justin Bo-Kai Hsu,1 Cheng-Yu Chen3,4,6,9 1Department of Medical Research, Taipei Medical University Hospital, Taipei, Taiwan; 2Department of Microbiology and Immunology, School o...
Main Authors: | Lee GA, Lin WL, Kuo DP, Li YT, Chang YW, Chen YC, Huang SW, Hsu JBK, Chen CY |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-07-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/detection-of-pd-l1-expression-in-temozolomide-resistant-glioblastoma-b-peer-reviewed-fulltext-article-IJN |
Similar Items
-
Identification of epidermal growth factor receptor-positive glioblastoma using lipid-encapsulated targeted superparamagnetic iron oxide nanoparticles in vitro
by: Huai-Lu Chen, et al.
Published: (2017-11-01) -
A facile method to prepare superparamagnetic iron oxide and hydrophobic drug-encapsulated biodegradable polyurethane nanoparticles
by: Cheng K, et al.
Published: (2017-03-01) -
Evaluation of Toxicity and Neural Uptake In Vitro and In Vivo of Superparamagnetic Iron Oxide Nanoparticles
by: Muhammad Kamran Khalid, et al.
Published: (2018-09-01) -
Directing the migration of mesenchymal stem cells with superparamagnetic iron oxide nanoparticles
by: Sotto, David C.
Published: (2016) -
Effect of combined anti-PD-1 and temozolomide therapy in glioblastoma
by: Junseong Park, et al.
Published: (2019-01-01)